Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dean R Madden

Showing results (21-30 of 68) with videos related to

Pageof 7
Sort By:
Plos One|August 20, 2014
Chemically modified peptide scaffolds target the CFTR-associated ligand PDZ domainJeanine F Amacher, Ruizhi Zhao, Mark R Spaller, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|January 9, 2010
Purification, crystallization and preliminary X-ray diffraction analysis of Cif, a virulence factor secreted by Pseudomonas aeruginosaChristopher D Bahl, Daniel P MacEachran, George A O'Toole, et al.
Biochemistry|August 30, 2008
The relative binding affinities of PDZ partners for CFTR: a biochemical basis for efficient endocytic recyclingPatrick R Cushing, Abigail Fellows, Daniel Villone, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|May 6, 2011
Crystallization and preliminary diffraction analysis of the CAL PDZ domain in complex with a selective peptide inhibitorJeanine F Amacher, Patrick R Cushing, Joshua A Weiner, et al.
Bioorganic & Medicinal Chemistry Letters|May 28, 2017
Optimization of the process of inverted peptides (PIPE<sup>PLUS</sup>) to screen PDZ domain ligandsQuentin Seisel, Marisa Rädisch, Nicholas P Gill, et al.
Molecular Pharmacology|June 30, 2009
A nondesensitizing kainate receptor point mutantNaushaba Nayeem, Yihong Zhang, Devin K Schweppe, et al.
Structure (London, England : 1993)|November 12, 2013
Stereochemical preferences modulate affinity and selectivity among five PDZ domains that bind CFTR: comparative structural and sequence analysesJeanine F Amacher, Patrick R Cushing, Lionel Brooks, et al.
The Journal of Biological Chemistry|December 18, 2012
Stereochemical determinants of C-terminal specificity in PDZ peptide-binding domains: a novel contribution of the carboxylate-binding loopJeanine F Amacher, Patrick R Cushing, Christopher D Bahl, et al.
Plos One|March 17, 2011
Crystal structure of a charge engineered human lysozyme having enhanced bactericidal activityAvinash Gill, Thomas C Scanlon, Daniel C Osipovitch, et al.
Plos Computational Biology|April 26, 2012
Computational design of a PDZ domain peptide inhibitor that rescues CFTR activityKyle E Roberts, Patrick R Cushing, Prisca Boisguerin, et al.
Pageof 7

Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
Plos One|August 20, 2014
Chemically modified peptide scaffolds target the CFTR-associated ligand PDZ domainJeanine F Amacher, Ruizhi Zhao, Mark R Spaller, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|January 9, 2010
Purification, crystallization and preliminary X-ray diffraction analysis of Cif, a virulence factor secreted by Pseudomonas aeruginosaChristopher D Bahl, Daniel P MacEachran, George A O'Toole, et al.
Biochemistry|August 30, 2008
The relative binding affinities of PDZ partners for CFTR: a biochemical basis for efficient endocytic recyclingPatrick R Cushing, Abigail Fellows, Daniel Villone, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|May 6, 2011
Crystallization and preliminary diffraction analysis of the CAL PDZ domain in complex with a selective peptide inhibitorJeanine F Amacher, Patrick R Cushing, Joshua A Weiner, et al.
Bioorganic & Medicinal Chemistry Letters|May 28, 2017
Optimization of the process of inverted peptides (PIPE<sup>PLUS</sup>) to screen PDZ domain ligandsQuentin Seisel, Marisa Rädisch, Nicholas P Gill, et al.
Molecular Pharmacology|June 30, 2009
A nondesensitizing kainate receptor point mutantNaushaba Nayeem, Yihong Zhang, Devin K Schweppe, et al.
Structure (London, England : 1993)|November 12, 2013
Stereochemical preferences modulate affinity and selectivity among five PDZ domains that bind CFTR: comparative structural and sequence analysesJeanine F Amacher, Patrick R Cushing, Lionel Brooks, et al.
The Journal of Biological Chemistry|December 18, 2012
Stereochemical determinants of C-terminal specificity in PDZ peptide-binding domains: a novel contribution of the carboxylate-binding loopJeanine F Amacher, Patrick R Cushing, Christopher D Bahl, et al.
Plos One|March 17, 2011
Crystal structure of a charge engineered human lysozyme having enhanced bactericidal activityAvinash Gill, Thomas C Scanlon, Daniel C Osipovitch, et al.
Plos Computational Biology|April 26, 2012
Computational design of a PDZ domain peptide inhibitor that rescues CFTR activityKyle E Roberts, Patrick R Cushing, Prisca Boisguerin, et al.
Pageof 7